Physician profile
Allison C Calhoun
NPI 1215374590
$131,783.14
in general payments reported to CMS, 2019-2025
21 companies · $6,224 in 2025
The $6,224 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,350 · 2020: $24K · 2021: $24K · 2022: $24K · 2023: $34K · 2024: $18K · 2025: $6,224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $58K · Food and Beverage: $331.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $57,500.00 |
| Food and Beverage | $330.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kedplasma LLC | $130,500.00 | 2019-2025 | |
| Abbvie INC. | $194.32 | 2020-2023 | Oriahnn, Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $169.02 | 2020-2025 | Myosure Tissue Removal Device, Acessa Provu System, Novasure |
| Boston Scientific Corporation | $122.34 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $119.55 | 2019-2025 | |
| Exeltis, USA INC. | $89.93 | 2019-2025 | Slynd |
| Roche Diagnostics Corporation | $88.46 | 2019 | |
| Astellas Pharma US INC | $79.53 | 2019-2024 | Veozah |
| Aspira Women'S Health INC | $64.58 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $58.58 | 2021-2022 | |
| Daiichi Sankyo INC. | $56.26 | 2019-2021 | |
| Coopersurgical, INC. | $39.77 | 2020-2022 | |
| Baxter Healthcare | $35.49 | 2024-2025 | Perclot |
| Myovant Sciences INC. | $28.79 | 2021-2022 | |
| Therapeuticsmd, INC. | $26.08 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $25.38 | 2019-2020 | |
| Sage Therapeutics, LLC | $19.42 | 2024 | |
| Evofem Biosciences, INC. | $18.65 | 2024 | |
| Sanofi Pasteur INC. | $17.30 | 2025 | |
| Amgen INC. | $15.12 | 2019 | |
| Duchesnay USA Incorporated | $14.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Calhoun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.